Mark Cuban's Investment in Matrix Analytics Supports Lung Cancer Detection

Denver-based client Matrix Analytics recently closed seed-round investment from businessman and philanthropist Mark Cuban. The capital will be used to increase distribution of its software application solution LungDirect, the only automatic registry software system enabling hospitals to track pulmonary nodule patients from detection through diagnosis. LungDirect is an innovative approach in nodule management that identifies all nodule patients and registers them in an end-user dashboard to better coordinate and manage both lung cancer screening patients and other at-risk pulmonary nodule patients.

The capital investment legal team was led by Denver partner Betty Arkell and Christie DiNapoli.

For more information, please see Matrix Analytics’ press release.


Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.